ARTBIO
Calvin J. Lee is the Finance Director at ARTBIO, a clinical-stage radiopharmaceutical biotech company. Prior to this, he held positions at Novartis Pharma Nederland as Head of Finance for Novartis Oncology Netherlands, Novartis Oncology as Head of Business Planning & Analysis for Novartis Oncology Europe, and Novartis as part of the Finance Development Program. He also has experience at CJ CheilJedang, Rosen & Associates Limited, and Deloitte & Touche LLP. Calvin holds a Bachelor of Commerce degree from the University of Toronto and an MBA from IESE Business School.
This person is not in any teams
This person is not in any offices
ARTBIO
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.